These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23981511)

  • 41. Habituation of the auditory evoked potential in a short interstimulus interval paradigm.
    Ozesmi C; Dolu N; Süer C; Gölgeli A; Aşçioglu M
    Int J Neurosci; 2000 Nov; 105(1-4):87-95. PubMed ID: 11069049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome.
    Wirojanan J; Jacquemont S; Diaz R; Bacalman S; Anders TF; Hagerman RJ; Goodlin-Jones BL
    J Clin Sleep Med; 2009 Apr; 5(2):145-50. PubMed ID: 19968048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-changed normative auditory event-related potential value in children in Taiwan.
    Tsai ML; Hung KL; Tao-Hsin Tung W; Chiang TR
    J Formos Med Assoc; 2012 May; 111(5):245-52. PubMed ID: 22656394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA).
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Saletu B; Zeitlhofer J
    Sleep Med; 2009 Sep; 10(8):850-8. PubMed ID: 19342295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sensory Processing Phenotypes in Fragile X Syndrome.
    Rais M; Binder DK; Razak KA; Ethell IM
    ASN Neuro; 2018; 10():1759091418801092. PubMed ID: 30231625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metformin treatment in young children with fragile X syndrome.
    Biag HMB; Potter LA; Wilkins V; Afzal S; Rosvall A; Salcedo-Arellano MJ; Rajaratnam A; Manzano-Nunez R; Schneider A; Tassone F; Rivera SM; Hagerman RJ
    Mol Genet Genomic Med; 2019 Nov; 7(11):e956. PubMed ID: 31520524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study).
    Ruiz-Antoran B; Sancho-López A; Cazorla-Calleja R; López-Pájaro LF; Leiva Á; Iglesias-Escalera G; Marín-Serrano ME; Rincón-Ortega M; Lara-Herguedas J; Rossignoli-Palomeque T; Valiente-Rodríguez S; González-Marques J; Román-Riechmann E; Avendaño-Solá C
    Orphanet J Rare Dis; 2018 Aug; 13(1):144. PubMed ID: 30126448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic minocycline treatment improves social recognition memory in adult male Fmr1 knockout mice.
    Yau SY; Chiu C; Vetrici M; Christie BR
    Behav Brain Res; 2016 Oct; 312():77-83. PubMed ID: 27291517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of auditory P300 habituation from active and passive conditions.
    Polich J; McIsaac HK
    Int J Psychophysiol; 1994 Jun; 17(1):25-34. PubMed ID: 7961051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis.
    Luu S; Province H; Berry-Kravis E; Hagerman R; Hessl D; Vaidya D; Lozano R; Rosselot H; Erickson C; Kaufmann WE; Budimirovic DB
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32932789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial.
    Yang JC; Rodriguez A; Royston A; Niu YQ; Avar M; Brill R; Simon C; Grigsby J; Hagerman RJ; Olichney JM
    Sci Rep; 2016 Feb; 6():21719. PubMed ID: 26898832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted Treatments for Fragile X Syndrome.
    Johnson D; Clark C; Hagerman R
    Adv Neurobiol; 2023; 30():225-253. PubMed ID: 36928853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The spatio-temporal dynamics of deviance and target detection in the passive and active auditory oddball paradigm: a sLORETA study.
    Justen C; Herbert C
    BMC Neurosci; 2018 Apr; 19(1):25. PubMed ID: 29673322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying large-scale brain networks in fragile X syndrome.
    Hall SS; Jiang H; Reiss AL; Greicius MD
    JAMA Psychiatry; 2013 Nov; 70(11):1215-23. PubMed ID: 24068330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered auditory processing in a mouse model of fragile X syndrome.
    Rotschafer S; Razak K
    Brain Res; 2013 Apr; 1506():12-24. PubMed ID: 23458504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Auditory N1 event-related potential amplitude is predictive of serum concentration of BPN14770 in fragile x syndrome.
    Norris JE; Berry-Kravis EM; Harnett MD; Reines SA; Reese MA; Outterson AH; Michalak C; Furman J; Gurney ME; Ethridge LE
    Res Sq; 2024 Jun; ():. PubMed ID: 38946987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome.
    Grieco JC; Ciarlone SL; Gieron-Korthals M; Schoenberg MR; Smith AG; Philpot RM; Heussler HS; Banko JL; Weeber EJ
    BMC Neurol; 2014 Dec; 14():232. PubMed ID: 25491305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fragile X syndrome.
    Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
    Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome.
    Goswami S; Cavalier S; Sridhar V; Huber KM; Gibson JR
    Neurobiol Dis; 2019 Apr; 124():563-572. PubMed ID: 30639292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Event-related potential alterations in fragile X syndrome.
    Knoth IS; Lippé S
    Front Hum Neurosci; 2012; 6():264. PubMed ID: 23015788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.